2022-08-26 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 50,000 0.1417% | $0.45 | $22,500 | -51.05% | ||
2021-10-13 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 58,824 <0.0001% | $0.85 | $50,000 | -79.52% | ||
2021-07-29 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 26,200 <0.0001% | $1.26 | $33,096 | -72.15% | ||
2021-05-18 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 20,000 <0.0001% | $1.61 | $32,200 | -55.66% | ||
2021-03-23 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 12,500 <0.0001% | $2.00 | $25,030 | -47.07% | ||
2020-12-07 | Sale | Insmed Incorporated INSM | director | 40,000 0.0394% | $39.57 | $1.58M | -24.76% | |
2020-02-27 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 20,000 <0.0001% | $2.71 | $54,200 | +4.01% | ||
2019-06-10 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 40,000 <0.0001% | $1.27 | $50,800 | +53.54% | ||
2019-03-25 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 50,000 <0.0001% | $1.54 | $77,000 | -3.59% | ||
2019-02-26 | Sale | Insmed Incorporated INSM | director | 11,000 0.0143% | $30.00 | $330,000 | -21.12% | |
2019-02-15 | Sale | Insmed Incorporated INSM | director | 11,000 0.0144% | $27.50 | $302,500 | -13.63% | |
2019-02-05 | Sale | Insmed Incorporated INSM | director | 11,000 0.0141% | $25.00 | $275,000 | -6.79% | |
2019-01-10 | Sale | Insmed Incorporated INSM | director | 11,000 0.0142% | $22.50 | $247,500 | +4.64% | |
2017-08-25 | Agile Therapeutics, Inc. AGRX | Chairman & Chief Executive Off | 20,000 <0.0001% | $3.34 | $66,800 | -4.2% | ||
2017-05-11 | Agile Therapeutics, Inc. AGRX | Chairman and Chief Executive O | 20,000 <0.0001% | $3.51 | $70,200 | +3.86% | ||
2015-06-02 | Agile Therapeutics, Inc. AGRX | Chief Executive Officer | 5,000 <0.0001% | $8.73 | $43,650 | -12.16% |